Understanding Ebola and other emerging infectious diseases to improve patient outcomes.
LEIDOS FUNDING TO59, OPTION 3
This study is looking to learn more about Ebola and other new infectious diseases to find out what helps patients get better and how to improve medical care for them, so we can be better prepared to handle these illnesses together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11197862 on NIH RePORTER |
What this research studies
This research focuses on gaining a deeper understanding of Ebola and other emerging infectious diseases. It aims to identify the factors that influence patient outcomes and develop strategies to enhance medical care for those affected. The approach includes collaboration with various stakeholders and utilizing advanced information technology to gather and analyze data. By improving protocols and support systems, the research seeks to ensure better preparedness and response to these infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Ebola or other emerging infectious diseases.
Not a fit: Patients with non-infectious diseases or those not affected by Ebola or similar infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved medical outcomes and treatment protocols for patients suffering from Ebola and other infectious diseases.
How similar studies have performed: Previous research has shown success in improving outcomes for patients with infectious diseases through enhanced understanding and protocol development.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.